![]() |
市場調查報告書
商品編碼
1813304
2032 年自動化液體處理市場預測:按產品、組件、技術、應用、最終用戶和地區進行的全球分析Automated Liquid Handling Market Forecasts to 2032 - Global Analysis By Product, Component, Technology, Application, End User and By Geography |
根據 Stratistics MRC 預測,全球自動化液體處理市場規模預計在 2025 年將達到 26.4 億美元,到 2032 年將達到 60.3 億美元,預測期內的複合年成長率為 12.5%。自動化液體處理是指在實驗室環境中使用機器人系統和精密儀器準確且有效率地轉移、分配和操作液體。該技術最大限度地減少了人為干預,降低了錯誤、污染和重複性任務的風險,同時提高了可重複性和通量。自動化液體處理廣泛應用於藥物發現、基因組學、蛋白質組學和臨床診斷等應用領域,可簡化涉及微孔盤、試管和其他實驗室器皿的複雜工作流程。透過整合先進的軟體、感測器和機器人技術,這些系統可以實現精確的體積控制、樣品追蹤和高通量處理,最終加速研究、提高數據品質並支援大規模實驗研究。
實驗室自動化的進步
與機器人技術和人工智慧的整合可提高可重複性並提升營運效率。對速度、可擴展性和資料完整性日益成長的需求,正在推動實驗室自動化的廣泛應用。微型移液技術和非接觸式工作流程正在基因組學、蛋白質組學和藥物研發領域開闢新的應用。隨著自動化成為工作流程現代化的核心,實驗室基礎設施的轉型也正在進行中。系統設計和功能的持續創新將增強其長期的市場相關性。
對熟練人才的需求
培訓成本和營運準備往往是小型設施面臨的障礙。系統整合和故障排除的複雜性往往會延長部署時間。對專業操作員的要求會增加整體擁有成本。這些營運障礙在資源受限的環境中顯著降低了採用率。因此,市場滲透率參差不齊,尤其是在缺乏技術基礎設施的地區。
慢性病增多
癌症和糖尿病等疾病需要可擴展且精準的檢測平台。自動化技術可確保樣本處理的一致性,並加速診斷工作流程。醫院和實驗室正在投資基礎設施,以管理日益成長的患者群體。與基因組學和蛋白質組學工具的整合支持先進的疾病分析。這些因素正在推動市場持續成長。
供應鏈和營運中斷
零件短缺和運輸延誤阻礙了生產和交付。技術支援和備件供應受限可能會擾亂實驗室的運作。疫情或貿易限制等外部衝擊會加劇這些脆弱性。實驗室效率可能會下降,停機時間也可能增加。這些問題威脅著市場擴張的可靠性。
由於高通量檢測、疫苗研發和治療藥物研究的迫切需求,COVID-19疫情顯著加速了對自動化液體處理系統的需求。世界各地的實驗室都優先考慮自動化,以減少人工勞動、提高準確性並最大程度地降低污染風險。雖然供應鏈中斷最初延遲了設備的供應,但投資的增加和政府的支持促進了市場的採用。此外,生物安全意識的增強以及對更有效率診斷和研究工作流程的需求,也增強了對自動化液體處理技術的長期依賴。
預計硬體部分將成為預測期內最大的部分
由於硬體在自動化液體處理平台中發揮關鍵作用,預計在預測期內將佔據最大的市場佔有率。機器人模組、移液系統和分配單元構成了這些解決方案的支柱。市場對可自訂且強大的硬體配置的需求日益成長。軟體整合可在工作流程中提供更強大的控制力和適應性。製造商優先考慮精度和模組化,以滿足實驗室不斷變化的需求。預計未來幾年,該領域將繼續成為主要的市場驅動力。
預計臨床診斷領域在預測期內的複合年成長率最高
由於對快速可靠檢測的需求不斷成長,臨床診斷領域預計將在預測期內實現最高成長率。自動化系統簡化了PCR、免疫檢測和分子診斷的樣本處理。慢性病和感染疾病負擔的日益惡化正在推動實驗室升級。與數位工具的整合可提高合規性和資料管理水準。分散式檢查模式正在提升系統的採用率。該領域預計將在整個醫療保健市場加速成長。
預計在預測期內,北美將佔據最大的市場佔有率,這得益於其成熟的製藥、生物技術和研究領域。全自動系統的採用正在不斷增加,以提高實驗室的精度、通量和可重複性。個人化醫療、藥物研發和診斷的需求日益成長,推動著市場擴張。機器人平台和先進配藥系統等技術創新正被廣泛整合。產業領袖的加入以及對實驗室自動化基礎設施的持續投資,正推動美國和加拿大市場的穩定成長。
在預測期內,由於對生物技術、製藥和學術研究的投資不斷增加,預計亞太地區將呈現最高的複合年成長率。對高通量篩檢、基因組學和蛋白質組學日益成長的需求正在推動相關技術的採用,尤其是在新興經濟體。自動化可以減少人為錯誤並提高實驗室效率。策略合作和日益成長的醫療基礎設施建設正在進一步加速市場發展。在政府措施的支持以及對研發和實驗室現代化日益重視的推動下,中國、日本和印度等國家正引領市場發展。
According to Stratistics MRC, the Global Automated Liquid Handling Market is accounted for $2.64 billion in 2025 and is expected to reach $6.03 billion by 2032 growing at a CAGR of 12.5% during the forecast period. Automated liquid handling refers to the use of robotic systems and precision instruments to accurately and efficiently transfer, dispense, and manipulate liquids in laboratory settings. This technology minimizes human intervention, reducing errors, contamination risks, and repetitive strain while enhancing reproducibility and throughput. Widely used in applications such as drug discovery, genomics, proteomics, and clinical diagnostics, automated liquid handling streamlines complex workflows involving microplates, test tubes, and other labware. By integrating advanced software, sensors, and robotics, these systems allow precise volume control, sample tracking, and high-throughput processing, ultimately accelerating research, improving data quality, and supporting large-scale experimental studies.
Advancements in laboratory automation
Integration with robotics and artificial intelligence improves reproducibility and enhances operational efficiency. Rising demand for speed, scalability, and data integrity is prompting widespread adoption of automation across laboratories. Miniaturized dispensing technologies and contactless workflows are unlocking new applications in genomics, proteomics, and drug discovery. Transformation of laboratory infrastructure is underway as automation becomes central to workflow modernization. Continued innovation in system design and functionality is reinforcing long-term market relevance.
Need for skilled personnel
Training costs and operational preparedness often pose barriers for smaller institutions. System integration and troubleshooting complexities tend to prolong deployment timelines. Specialized operator requirements contribute to elevated total cost of ownership. Adoption rates are notably lower in resource-constrained environments due to these operational hurdles. Market penetration is therefore uneven, particularly in regions lacking technical infrastructure.
Growing prevalence of chronic diseases
Diseases like cancer and diabetes demand scalable and precise testing platforms. Automation ensures consistent sample handling and accelerates diagnostic workflows. Hospitals and labs are investing in infrastructure to manage rising patient volumes. Integration with genomic and proteomic tools supports advanced disease profiling. These factors are fueling sustained market momentum.
Supply chain and operational disruptions
Component shortages and shipping delays hinder manufacturing and delivery. Limited access to technical support or spare parts can interrupt lab operations. External shocks such as pandemics or trade restrictions amplify these vulnerabilities. Laboratories may encounter reduced efficiency or downtime. These issues threaten the reliability of market expansion.
The Covid-19 pandemic significantly accelerated the demand for automated liquid handling systems due to the urgent need for high-throughput testing, vaccine development, and research on therapeutics. Laboratories worldwide prioritized automation to reduce manual handling, enhance accuracy, and minimize contamination risks. Supply chain disruptions initially slowed equipment availability, but increased investments and government support boosted market adoption. Additionally, heightened awareness of biosecurity and efficiency in diagnostic and research workflows reinforced the long-term reliance on automated liquid handling technologies.
The hardware segment is expected to be the largest during the forecast period
The hardware segment is expected to account for the largest market share during the forecast period owing to its essential role in automated liquid handling platforms. Robotic modules, pipetting systems, and dispensing units form the backbone of these solutions. Demand is growing for customizable and robust hardware configurations. Software integration enhances control and adaptability across workflows. Manufacturers are prioritizing precision and modularity to meet evolving lab requirements. This segment will remain the primary revenue driver.
The clinical diagnostics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the clinical diagnostics segment is predicted to witness the highest growth rate due to rising demand for fast and reliable testing. Automated systems streamline sample processing for PCR, immunoassays, and molecular diagnostics. The growing burden of chronic and infectious diseases is prompting lab upgrades. Integration with digital tools improves compliance and data management. Decentralized testing models are expanding system usage. This segment is poised for accelerated growth across healthcare markets.
During the forecast period, the North America region is expected to hold the largest market share by well-established pharmaceutical, biotechnology, and research sectors. There is strong adoption of fully automated systems to enhance precision, throughput, and reproducibility in laboratories. Increasing demand for personalized medicine, drug discovery, and diagnostics fuels market expansion. Technological innovations, such as robotic platforms and advanced pipetting systems, are widely integrated. The presence of major industry players and continuous investments in laboratory automation infrastructure contribute to steady growth across the U.S. and Canada.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing investments in biotechnology, pharmaceuticals, and academic research. Growing demand for high-throughput screening, genomics, and proteomics is driving adoption, especially in emerging economies. Automation helps reduce human error and improve laboratory efficiency. Strategic collaborations and rising healthcare infrastructure development are further accelerating market growth. Countries like China, Japan, and India are leading the market, supported by government initiatives and a growing focus on R&D and laboratory modernization.
Key players in the market
Some of the key players in Automated Liquid Handling Market include Thermo Fisher Scientific, Hamilton Company, PerkinElmer, Tecan Group, Agilent Technologies, Danaher Corporation, Formulatrix Inc., Mettler-Toledo International Inc., Becton Dickinson and Company, Aurora Biomed Inc., Eppendorf AG, Analytik Jena AG, Hudson Robotics Inc., Corning Incorporated, Gilson Inc.
In July 2025, Hamilton acquired UK Robotics and Trisonic Discovery to strengthen its integration and dispensing capabilities. The acquisition added dynamic scheduling software (RevoWeb) and acoustic dispensing technologies to Hamilton's portfolio, enabling scalable, contactless liquid handling for genomics, drug development, and diagnostics.
In February 2025, Thermo Fisher launched the Multidrop(TM) Combi+ and Multidrop(TM) Pico(TM) 8 dispensers at SLAS2025. These systems offer ultra-fast microliter and picoliter dispensing for reagents and cell lines, improving precision and throughput in pharmaceutical and biotech liquid handling applications.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.